Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567853 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
A Phase 3 study, sponsored by Sorin Group USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00567853 is a Phase 3 study that has completed, run by Sorin Group USA. The registered enrollment target is 278 participants.
The verdict
NCT00567853, a Phase 3 study, has completed, sponsored by Sorin Group USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data on the effectiveness and clinical outcomes of the MEMO 3D Annuloplasty ring as used for mitral valve repair.
Interventions
- DEVICE Implantation of the MEMO 3D Annuloplasty Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2007-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567853
The ClinicalTrials.gov registry entry for NCT00567853 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sorin Group USA, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of the MEMO 3D Annuloplasty Ring is the first listed.
NCT00567853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567853 about?
NCT00567853 is a clinical study titled "Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair". The purpose of this study is to collect data on the effectiveness and clinical outcomes of the MEMO 3D Annuloplasty ring as used for mitral valve repair.
What is the current status of trial NCT00567853?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2007-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00567853?
The interventions under investigation include: Implantation of the MEMO 3D Annuloplasty Ring (DEVICE).
Who is sponsoring clinical trial NCT00567853?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.